Johnson & Johnson's interest in acquiring Pfizer...........may have to do with Pfizer developing a new smoking cessation drug.
Since J & J has invested hundreds of millions of dollars into funding smoking ban legislation through their private foundation the Robert Wood Johnson Foundation, it makes sense that they would want to acquire a competitive company which could have benefitted from RWJF's funding of smoking bans.
"there has been considerable buzz among smoking-cessation doctors about a new Pfizer Inc. drug called varenicline, which the company plans to market this month under the brand name Chantix...." full story here.
But the fact that J & J is acquiring Pfizer.....while their foundation RWJF continues to fund smoking ban legislation......only bolster's the argument that they continue to fund smoking ban efforts to increase their profits.....not to improve your health.
Especially now that we know secondhand smoke is NOT a hazard.
( I might suggest that the SEC take a good long look at this merger)
Oh.... sorry Robert Wood Johnson IV and William C. Weldon....am I interferring with your livelihood?......welcome to my world.